Resolving Disease Mechanisms through Single-Cell Transcriptomic Landscapes

You are reading version 1 of this direction, frozen 2026-10-04. The latest version is version 2.

Version 1 of 2540 papers575 conceptsfrozen 2026-10-04

Traditional genomic analysis is often compared to a fruit smoothie: you can taste the overall flavor, but you cannot tell exactly how many strawberries were ripe or if a single bitter grape ruined the batch. For decades, "bulk" RNA sequencing provided an average signal across thousands of cells, effectively masking the rare, deviant, or transitional cell states that actually drive disease progression.

The shift toward single-cell transcriptomic profiling—primarily through single-cell RNA sequencing (scRNA-seq) and single-nucleus sequencing (snRNA-seq)—has replaced the smoothie with a fruit salad. By measuring gene expression within individual cells, researchers can now map the "cellular landscape" of a tissue, identifying exactly which cell types are present, how they are communicating, and where they are going wrong.

Breaking the Average

The power of single-cell analysis lies in its ability to resolve heterogeneity. In Alzheimer’s disease, for instance, bulk analysis might show a general increase in inflammatory markers. However, Hansruedi Mathys and colleagues demonstrated in Single-cell transcriptomic analysis of Alzheimer’s disease that these changes are not uniform. By partitioning data into distinct lineages like neurons and microglia, they could localize pathological signatures to specific functional units, revealing that early-stage disease looks fundamentally different at the cellular level than late-stage decay.

This resolution is particularly critical for identifying "primed" states—cells that look healthy but are molecularly prepared for a malfunction. Saskia Trump and Soeren Lukassen applied this to COVID-19, discovering that hypertensive patients have immune cells that are already "primed" for hyperinflammation before they even encounter the virus. This explains why certain populations face higher risks: their cellular baseline is closer to the cliff's edge.

Identifying Rare and Transitional States

In a complex tissue, the most important cells are often the rarest. Traditional methods often ignore these "outliers" as noise. Single-cell profiling, however, treats them as signals. Yufang Rao used this approach to find "dual-feature" cells in ear infections—rare non-professional phagocytes that play a disproportionate role in maintaining the local environment.

Similarly, in cancer, tumors are rarely a monolithic mass of identical cells. Teresa G. Krieger showed that pancreatic cancer subtypes, previously thought to be distinct patient categories, actually coexist within the same tumor as different stages of a developmental hierarchy. By mapping these transitions, researchers can identify the "basal-like" states that drive drug resistance.

Mapping the Social Network of Cells

Cells do not act in isolation; they exist in a microenvironment where they constantly signal to their neighbors. Single-cell data allows researchers to reconstruct these "vicious cycles." Robert Lorenz Chua identified a specific signaling axis (CCL2/CCL3-CCR1) between the airway epithelium and immune cells that drives lethal lung inflammation in COVID-19. Without single-cell resolution, it would be impossible to tell which cell was "talking" and which was "listening."

This "social mapping" extends to physical structure. Gareth Ball and Jakob Seidlitz linked macroscopic brain morphology at birth to microscopic gene expression patterns, showing that the physical folding of the brain is driven by the specific transcriptomic programs of glial cells.

From Clusters to Counterfactuals

As the field matures, the focus is shifting from simply "clustering" cells into groups to using AI to predict how they will behave. Traditional analysis requires researchers to pre-define cell types, which can introduce bias. New generative models like MrVI, developed by Pierre Boyeau and Elham Azizi, allow for sample-level analysis without predefined labels.

By using "counterfactual" logic—asking how a specific cell from a healthy patient would look if it were in a diseased environment—these models can pinpoint the exact subsets driving a phenotype. This moves the field toward precision medicine, where a patient's unique cellular landscape can predict their response to therapy, such as Rituparna Das’s work using early B cell changes to predict which patients will suffer autoimmune side effects from immunotherapy.

Papers in this version

Showing 60 of 540 papers.

History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 662 papers
  2. Version 1 · 2026-10-04 · 540 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_single_cell_rna_sequencing_6da9f919,
  title = {single-cell RNA sequencing},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/single-cell-rna-sequencing/rdr_6da9f91920bb445399c22552a24d18b0},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}

This exact version (version 1, frozen text):

@misc{lacuna_resolving_disease_mechanisms_through_sin_6da9f919_v1,
  title = {Resolving Disease Mechanisms through Single-Cell Transcriptomic Landscapes},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/resolving-disease-mechanisms-through-single-cell-transcriptomic-landscapes/rdr_6da9f91920bb445399c22552a24d18b0/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}